S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
Log in

NASDAQ:CYRX - CryoPort Stock Price, Forecast & News

$14.62
+0.10 (+0.69 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$14.43
Now: $14.62
$14.80
50-Day Range
$13.79
MA: $14.77
$15.77
52-Week Range
$8.28
Now: $14.62
$25.02
Volume308,974 shs
Average Volume381,891 shs
Market Capitalization$524.04 million
P/E RatioN/A
Dividend YieldN/A
Beta0.8
CryoPort, Inc engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. Read More…

Industry, Sector and Symbol

Industry Freight transportation arrangement
Sub-IndustryN/A
SectorTransportation
Current SymbolNASDAQ:CYRX
CUSIPN/A
Phone949-470-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$19.63 million
Book Value$1.27 per share

Profitability

Net Income$-9,560,000.00

Miscellaneous

EmployeesN/A
Market Cap$524.04 million
Next Earnings Date3/5/2020 (Estimated)
OptionableOptionable

Receive CYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter.


CryoPort (NASDAQ:CYRX) Frequently Asked Questions

What is CryoPort's stock symbol?

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

How were CryoPort's earnings last quarter?

CryoPort Inc (NASDAQ:CYRX) released its earnings results on Thursday, November, 7th. The consumer goods maker reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.02. The consumer goods maker had revenue of $9.58 million for the quarter, compared to analysts' expectations of $9.49 million. CryoPort had a negative net margin of 64.63% and a negative return on equity of 26.50%. CryoPort's revenue for the quarter was up 81.1% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.07) EPS. View CryoPort's Earnings History.

When is CryoPort's next earnings date?

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

What price target have analysts set for CYRX?

4 brokers have issued 1 year target prices for CryoPort's shares. Their forecasts range from $22.00 to $26.00. On average, they expect CryoPort's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 64.2% from the stock's current price. View Analyst Price Targets for CryoPort.

What is the consensus analysts' recommendation for CryoPort?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

Has CryoPort been receiving favorable news coverage?

Headlines about CYRX stock have been trending extremely negative this week, InfoTrie reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CryoPort earned a coverage optimism score of -4.3 on InfoTrie's scale. They also assigned news articles about the consumer goods maker a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for CryoPort.

Are investors shorting CryoPort?

CryoPort saw a decrease in short interest in the month of October. As of October 15th, there was short interest totalling 6,220,000 shares, a decrease of 13.6% from the September 15th total of 7,200,000 shares. Based on an average trading volume of 660,200 shares, the short-interest ratio is currently 9.4 days. Approximately 17.7% of the shares of the stock are short sold. View CryoPort's Current Options Chain.

Who are some of CryoPort's key competitors?

What other stocks do shareholders of CryoPort own?

Who are CryoPort's key executives?

CryoPort's management team includes the folowing people:
  • Jerrell W. Shelton, Chairman, President & Chief Executive Officer
  • Phil Wilson, SVP-Global Operations & Supply Chain
  • Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer
  • Bret Bollinger, Chief Technology Officer
  • Mark W. Sawicki, Chief Commercial Officer

Who are CryoPort's major shareholders?

CryoPort's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Chevy Chase Trust Holdings Inc. (4.61%), TimesSquare Capital Management LLC (3.78%), State Street Corp (2.61%), Columbus Circle Investors (0.99%), Creative Planning (0.97%) and Granahan Investment Management Inc. MA (0.93%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.

Which institutional investors are selling CryoPort stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Millennium Management LLC, Perkins Capital Management Inc., Taylor Frigon Capital Management LLC, Essex Investment Management Co. LLC, D.A. Davidson & CO., Rice Hall James & Associates LLC and Taylor Wealth Management Partners. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman and Robert Stefanovich. View Insider Buying and Selling for CryoPort.

Which institutional investors are buying CryoPort stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Chevy Chase Trust Holdings Inc., Columbus Circle Investors, State Street Corp, SG Capital Management LLC, Granahan Investment Management Inc. MA, Castleark Management LLC and SG Americas Securities LLC. View Insider Buying and Selling for CryoPort.

How do I buy shares of CryoPort?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is CryoPort's stock price today?

One share of CYRX stock can currently be purchased for approximately $14.62.

How big of a company is CryoPort?

CryoPort has a market capitalization of $524.04 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

What is CryoPort's official website?

The official website for CryoPort is http://www.cryoport.com/.

How can I contact CryoPort?

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]


MarketBeat Community Rating for CryoPort (NASDAQ CYRX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  315
MarketBeat's community ratings are surveys of what our community members think about CryoPort and other stocks. Vote "Outperform" if you believe CYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Quiet Period Expirations

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel